WELCOME TO THE HYLORIS INVESTOR RELATIONS PAGE

Innovation for a healthier tomorrow

Shareholder information

Shareholder information

VIEW MORE
Share stock price

Share price

VIEW MORE
Financial information

Financial information

View more

Press Releases

01.12.20 Hyloris reinforces its Board of Directors with the nomination of Chris Buyse
EN
FR
27.11.20 Information on the total number of voting rights and shares – additional thresholds
EN
FR
04.11.20 Distribution agreements for Maxigesic® IV in the UK and Hong Kong
EN
FR
27.10.20 Hyloris to present at upcoming European investor conferences
EN
FR
VIEW ALL PRESS RELEASES
What Hyloris does
Hyloris Pharmaceuticals Investors
Contact us